Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | GSK | REGN | ||
| Company | Vertex Pharmaceutic | Gsk Plc ADR | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 431.25 | 50.44 | 717.33 | ||
| High | 431.77 | 50.44 | 717.33 | ||
| Low | 426.68 | 50.44 | 717.33 | ||
| Latest | 430.14 | 50.44 | 717.33 | ||
| Change | +4.13 | -4.03 | -14.44 | ||
| % Change | +0.97% | -7.40% | -1.97% | ||
| Volume | 808,500 | 367,052 | 3,325 | ||
| 20-Day Average Volume | 1,091,640 | 3,746,983 | 663,420 | ||
| Previous Close | 426.01 | 54.47 | 744.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 438.17 | 56.43 | 755.85 | ||
| 20-Day Raw Stochastic | 16.99% | 0.00% | 1.73% | ||
| 20-Day Relative Strength | 42.49 | 34.83 | 43.40 | ||
| Weighted Alpha | -10.33 | +24.81 | +22.52 | ||
| Today's Opinion | 40% Sell | 24% Buy | 24% Sell | ||
| Previous Opinion | 40% Sell | 64% Buy | 8% Buy | ||
| Last Month's Opinion | 8% Sell | 56% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.48% since 04/21/26 | -9.44% since 04/22/26 | -2.09% since 04/21/26 | ||
| Low | 425.86 on 04/27/26 | 50.44 on 04/29/26 | 730.90 on 04/28/26 | ||
| High | 442.04 on 04/23/26 | 56.19 on 04/23/26 | 767.21 on 04/23/26 | ||
| 1-Month | |||||
| %Chg | -0.68% since 03/27/26 | -6.32% since 03/27/26 | -0.81% since 03/27/26 | ||
| Low | 425.26 on 04/07/26 | 50.44 on 04/29/26 | 730.90 on 04/28/26 | ||
| High | 453.98 on 04/01/26 | 59.57 on 04/14/26 | 781.21 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | -10.00% since 01/28/26 | -0.43% since 01/29/26 | -2.58% since 01/28/26 | ||
| Low | 425.26 on 04/07/26 | 50.44 on 04/29/26 | 727.88 on 03/19/26 | ||
| High | 507.92 on 03/10/26 | 61.69 on 02/18/26 | 815.00 on 02/17/26 | ||
| 6-Month | |||||
| %Chg | +1.83% since 10/28/25 | +9.82% since 10/29/25 | +11.81% since 10/28/25 | ||
| Low | 403.16 on 11/04/25 | 45.81 on 11/20/25 | 625.14 on 11/04/25 | ||
| High | 507.92 on 03/10/26 | 61.69 on 02/18/26 | 821.11 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 109,410,408 | 110,530,416 | 77,362,728 | ||
| Shares Outstanding, K | 254,360 | 2,029,198 | 105,720 | ||
| Annual Sales | 12,001,300,000 | 43,077,970,000 | 14,342,900,000 | ||
| Annual Net Income | 3,953,200,000 | 7,537,690,000 | 4,504,900,000 | ||
| Last Quarter Sales | 3,190,000,000 | 11,424,970,000 | 3,884,300,000 | ||
| Last Quarter Net Income | 1,191,100,000 | 851,670,000 | 844,600,000 | ||
| 60-Month Beta | 0.36 | 0.46 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.03 on 02/12/26 | 0.68 on 02/04/26 | 11.44 on 01/30/26 | ||
| Earnings Date | 05/04/26 | 04/29/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | 0.470 on 02/20/26 | 0.940 on 02/20/26 | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 25.94 | 12.00 | 20.63 | ||